{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-116217","form_type":"8-K","ticker":"IRWD","cik":"0001446847","company_name":"IRONWOOD PHARMACEUTICALS INC","filed_at":"2025-11-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.430750+00:00","generated_at":"2026-05-16T16:27:08.689585+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"HHS sets LINZESS Maximum Fair Price at $136 per 30-day supply starting Jan 2027","bullets":["MFP for LINZESS (linaclotide) is $136 for a 30-day supply, effective January 1, 2027.","Ironwood says the MFP is in line with company expectations.","LINZESS was selected in the latest round of IRA government price setting.","MFP will become the new Medicare net price for the drug."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-116217","json":"https://secwatch.observer/filing/0001104659-25-116217.json","markdown":"https://secwatch.observer/filing/0001104659-25-116217.md","text":"https://secwatch.observer/filing/0001104659-25-116217.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446847/000110465925116217/0001104659-25-116217-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446847/000110465925116217/tm2532096d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T16:27:08.689585+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}